Somatolynk
UEI: QN6MFHAYSRZ9
• CAGE: 8TFG8
Overview
Awardee Type
Parent
Company Description
Somatolynk is a small molecule drug discovery and development company focused on Alzheimer's disease and associated symptoms
Name
Somatolynk
Website
Headquarters
Edwardsville, IL
United States
United States
Most Recent Award
Aug. 1, 2023
Calculating
Federal grant recipient
SOMATOLYNK INC
(UEI QN6MFHAYSRZ9, CAGE 8TFG8)
is headquartered in Edwardsville IL.
The corporation
was founded in July 2017 and
federally registered in
December 2020.
Federal Award Analysis
Somatolynk federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SOMATOLYNK INC
UEI
QN6MFHAYSRZ9
CAGE Code
8TFG8
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
July 31, 2017
Initial Registration
Dec. 3, 2020
Last Registration
Nov. 11, 2025
Registration Activation
Nov. 7, 2025
Registration Expiration
Nov. 5, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
Yes